longterm tobramycin therapy patient cystic fibrosis advanced pulmonary disease aim clinical study find prolonged tobramycin therapy prevent rapid deterioration cystic fibrosis patient eleven course treatment given nine patient eight markedly improved physical activity gained weight however four patient clinical improvement correlated improved radiogram pseudomonas eradicated sputum four patient therapy reappeared three end therapy clinical improvement negligible side effect suggest treatment exacerbating pyocyaneus bronchopneumonia prolonged tobramycin therapy dosage higher 5 mgkgday strict control tobramycin blood level awareness side effect